225 related articles for article (PubMed ID: 34067808)
21. [Role of natriuretic peptides in the assessment of aortic stenosis severity].
Davicević Z; Tavciovski D; Matunović R; Vukotić S; Mijailović Z
Vojnosanit Pregl; 2010 Aug; 67(8):622-6. PubMed ID: 20845663
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
23. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Endresen K; Bjørnerheim R; Hall C
Clin Cardiol; 2002 Apr; 25(4):174-80. PubMed ID: 12000075
[TBL] [Abstract][Full Text] [Related]
24. Preprocedural circulating galectin-3 and the risk of mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis.
Zhang HL; Song GY; Zhao J; Wang YB; Wang MY; Xu YL; Wang BC; Niu GN; Liu ZH; Wu YJ
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32893848
[TBL] [Abstract][Full Text] [Related]
25. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
26. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
27. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis.
Wang F; Wu Y; Tang L; Zhu W; Chen F; Xu T; Bo L; Li J; Deng X
Crit Care; 2012 May; 16(3):R74. PubMed ID: 22559153
[TBL] [Abstract][Full Text] [Related]
28. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
29. Stress-delta B-type Natriuretic Peptide Levels as a Test for Inducible Myocardial Ischemia: A Systematic Review and Meta-Analysis.
Kheang S; Rodrigues CG; Vissoci JRN; Hassan A; Muller C; Muller D; Limkakeng AT
Cureus; 2020 Mar; 12(3):e7165. PubMed ID: 32257708
[TBL] [Abstract][Full Text] [Related]
30. [Biomarkers for the evaluation of valvular aortic stenosis].
Weber M; Hamm C
Herz; 2006 Oct; 31(7):658-63. PubMed ID: 17072779
[TBL] [Abstract][Full Text] [Related]
31. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
32. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
[TBL] [Abstract][Full Text] [Related]
33. Periprocedural Changes of NT-proBNP Are Associated With Survival After Transcatheter Aortic Valve Implantation.
Seoudy H; Frank J; Neu M; Güßefeld N; Klaus Y; Freitag-Wolf S; Lambers M; Lutter G; Dempfle A; Rangrez AY; Kuhn C; Frey N; Frank D
J Am Heart Assoc; 2019 Feb; 8(3):e010876. PubMed ID: 30686097
[TBL] [Abstract][Full Text] [Related]
34. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
[TBL] [Abstract][Full Text] [Related]
35. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
36. Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic Stenosis.
Lindman BR; Clavel MA; Abu-Alhayja'a R; Côté N; Dagenais F; Novak E; Voisine P; Poulin A; Arsenault BJ; Desmeules P; Dahou A; Taster L; Aldahoun K; Bossé Y; Mathieu P; Pibarot P
JACC Cardiovasc Interv; 2018 Nov; 11(21):2172-2181. PubMed ID: 30409274
[TBL] [Abstract][Full Text] [Related]
37. The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
Kokkinidis DG; Papanastasiou CA; Jonnalagadda AK; Oikonomou EK; Theochari CA; Palaiodimos L; Karvounis HI; Armstrong EJ; Faillace RT; Giannakoulas G
Cardiovasc Revasc Med; 2018; 19(7 Pt B):859-867. PubMed ID: 29724516
[TBL] [Abstract][Full Text] [Related]
38. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers in Aortic Valve Stenosis and their Clinical Significance in Transcatheter Aortic Valve Implantation.
Toutouzas K; Stathogiannis K; Latsios G; Synetos A; Drakopoulou M; Penesopoulou V; Michelongona A; Tsiamis E; Tousoulis D
Curr Med Chem; 2019; 26(5):864-872. PubMed ID: 28748765
[TBL] [Abstract][Full Text] [Related]
40. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
